PRME
Prime Medicine, Inc.
2.90$
-5.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +0.0% | +1,220.9% | +291.5% | +109.2% | +31.7% | -12.1% | |
| – | – | +346.5% | +269.9% | +115.4% | +87.4% | +12.3% | |
| – | -211.0% | – | -94.5% | – | – | – | |
| – | -66.7% | +18,909.8% | -213.6% | – | +1,074.0% | -117.2% | |
| – | +0.0% | +549.5% | +287.8% | -45.8% | -16.4% | -37.9% | |
| – | +0.0% | +6,832.8% | -36.0% | – | +265.9% | -258.9% | |
| – | – | – | – | – | – | – | |
| – | +250.0% | +670.8% | -32.6% | -99.6% | +29,804.7% | -22.6% | |
| – | +227.6% | +470.4% | -98.4% | -5,780.5% | – | -184.7% | |
| – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.